Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Avalon GloboCare and University of Natural Resources and Life Sciences (BOKU) Expand .
Avalon GloboCare Corp.December 30, 2020 GMT
Aiming to accelerate the clinical development of S-layer nanotechnology for mucosal vaccines, hemo-filtration devices, cell-based therapies and other medical applications
Establishing state-of-the-art research facility at the University of Natural Resources and Life Sciences (BOKU) in Vienna, Austria, led by the developers and leading world experts on S-layer technology
Forming alliances with premiere biomedical research centers across Europe Avalon’s scientific capabilities featured in December 2020 issue of
Nature Biopharma Dealmakers